Jury says Johnson & Johnson owes $40 million to 2 cancer patients

A jury has mandated that pharmaceutical giant Johnson & Johnson must pay $40 million to two cancer patients who claimed their illnesses resulted from the use of the company’s talcum powders. This verdict represents another significant legal blow to J&J regarding the safety of their consumer products.

The plaintiffs successfully argued that the company failed to adequately warn consumers about potential health risks associated with long-term use of the product, leading to devastating cancer diagnoses.

This outcome adds to the multi-billion dollar legal liabilities J&J faces globally stemming from thousands of lawsuits related to talc products. The company has previously denied wrongdoing but continues to face heavy financial penalties in court.